Latest situation in 2024: How much does a box of neratinib/neratinib cost?

Neratinib/Neratinib (Neratinib), an innovative targeted therapy, has attracted widespread attention around the world. Neratinib offers a new treatment option for patients with certain types of hormone receptor-positive breast cancer who have been treated with trastuzumab and other drugs. At the same time, when combined with capecitabine, it becomes a powerful weapon against breast cancer that is advanced or has spread to other parts of the body.

At present, the original drug of neratinib has been launched in China and has entered the scope of Class B medical insurance. However, it should be noted that reimbursement by medical insurance is limited to patients who meet specific indications. In the market, the price of each box of the original drug neratinib with a specification of 40mg*180 tablets is approximately RMB 7,000. At the same time, the original drug of neratinib in overseas markets is more expensive, which may be as high as more than 10,000 US dollars per box.

Generic drugs of neratinib also exist in overseas markets. The pharmaceutical ingredients of these generic drugs are basically the same as those of domestic and foreign original drugs, but they have significant advantages in price. Take neratinib produced by Bangladesh Yaopin International as an example. The generic drug has a specification of 40mg*180 tablets. The price per box is about more than 2,000 yuan (the price may fluctuate due to exchange rates). This provides a more economical and affordable treatment option for the majority of patients.

Overall, neratinib brings new hope to breast cancer patients with its excellent efficacy and diverse treatment options. At the same time, the coexistence of original drugs and generic drugs also provides patients with more treatment options and economic considerations. In the future, with the continuous advancement of medical technology and the continuous optimization of medical policies, it is believed that high-quality drugs such as neratinib will bring good news to more patients.